Olanzapine discontinuation for schizophrenia-Reference-Cited by-同舟云学术

Olanzapine discontinuation for schizophrenia

Published:2012-03-14 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Alahdab Fares¹,Alhalabi Omar¹,Attwa Ghaith¹,Mousa Basha Ghaith¹,Adams Clive E²

Affiliation:

1. Damascus University; Faculty of Medicine; Daryya P.O. Box 5899 Damascus Syrian Arab Republic

2. University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health, Sir Colin Campbell Building, University of Nottingham Innovation Park, Triumph Road, Nottingham UK NG7 2TU

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD009693/fullpdf

Reference41 articles.

1. Detecting skewness from summary information;Altman;British Medical Journal,1996

2. Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses;Belgamwar;Cochrane Database of Systematic Reviews,2005

3. Olanzapine: an updated review of itsuse in the management of schizophrenia;Bhana;Drugs,2001

4. Statistics notes. Trials randomised in clusters;Bland;BMJ,1997

5. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use;Boissel;Therapie,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders;Cochrane Database of Systematic Reviews;2024-07-03

2. Haloperidol versus olanzapine for people with schizophrenia;Cochrane Database of Systematic Reviews;2019-10-30